作者
Timothy R Deer, Nagy Mekhail, David Provenzano, Jason Pope, Elliot Krames, Michael Leong, Robert M Levy, David Abejon, Eric Buchser, Allen Burton, Asokumar Buvanendran, Kenneth Candido, David Caraway, Michael Cousins, Michael DeJongste, Sudhir Diwan, Sam Eldabe, Kliment Gatzinsky, Robert D Foreman, Salim Hayek, Philip Kim, Thomas Kinfe, David Kloth, Krishna Kumar, Syed Rizvi, Shivanand P Lad, Liong Liem, Bengt Linderoth, Sean Mackey, Gladstone McDowell, Porter McRoberts, Lawrence Poree, Joshua Prager, Lou Raso, Richard Rauck, Marc Russo, Brian Simpson, Konstantin Slavin, Peter Staats, Michael Stanton-Hicks, Paul Verrills, Joshua Wellington, Kayode Williams, Richard North
发表日期
2014/8/1
来源
Neuromodulation: Technology at the Neural Interface
卷号
17
期号
6
页码范围
515-550
出版商
Elsevier
简介
Introduction
The Neuromodulation Appropriateness Consensus Committee (NACC) of the International Neuromodulation Society (INS) evaluated evidence regarding the safety and efficacy of neurostimulation to treat chronic pain, chronic critical limb ischemia, and refractory angina and recommended appropriate clinical applications.
Methods
The NACC used literature reviews, expert opinion, clinical experience, and individual research. Authors consulted the Practice Parameters for the Use of Spinal Cord Stimulation in the Treatment of Neuropathic Pain (2006), systematic reviews (1984 to 2013), and prospective and randomized controlled trials (2005 to 2013) identified through PubMed, EMBASE, and Google Scholar.
Results
Neurostimulation is relatively safe because of its minimally invasive and reversible characteristics. Comparison with medical management is difficult, as patients considered for …
学术搜索中的文章
TR Deer, N Mekhail, D Provenzano, J Pope, E Krames… - Neuromodulation: Technology at the Neural Interface, 2014
